Seeing Is Believing
Currently out of the existing stock ratings of Ziyi Chen, 2 are a HOLD (22.22%), 7 are a BUY (77.78%).
Analyst Ziyi Chen, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 23.33% that have a potential upside of 11.66% achieved within 65 days.
Ziyi Chen’s has documented 17 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ZLAB, Zai Lab Ltd at 26-Oct-2023.
Analyst best performing recommendations are on ZLAB (ZAI LAB LTD).
The best stock recommendation documented was for ZLAB (ZAI LAB LTD) at 4/27/2020. The price target of $77.23 was fulfilled within 53 days with a profit of $12.68 (19.64%) receiving and performance score of 3.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$288
$51.9 (21.98%)
$285
2 months 9 days ago
0/4 (0%)
$104.97 (57.35%)
Buy
$254
$17.9 (7.58%)
$236
5 months 8 days ago
4/7 (57.14%)
$85.36 (50.62%)
125
Hold
$164.3
$-71.8 (-30.41%)
$212
6 months 9 days ago
3/3 (100%)
$14.55 (9.72%)
135
Buy
$345
$108.9 (46.12%)
$350
7 months 20 days ago
2/5 (40%)
$165.31 (92.00%)
350
Buy
$319
$82.9 (35.11%)
$321
1 years 1 months 18 days ago
3/9 (33.33%)
$105.41 (49.35%)
126
What Year was the first public recommendation made by Ziyi Chen?